Favourites   Have ideas?  Sign in / Register

Positive:   Pharmaceutical  0.00   3D 0.00   Respiratory therapies / Pulmanory ↑1.36 «See more»   Biopharma ↑8.5   Disease: Kidney ↑15.32   Artificial Intelligence ↑15.32

Negative:


Country: Greate Britain segment

AUTL Autolus Therapeutics plc - American Depositary Shares 3.52% up -11.69% 15.21 + Country: Greate Britain, Gene and cell, Cancer fight, Medicine


Last highlighted: $AUTL Autolus Therapeutics to Report First Quarter 2021 Financial Results and Host Conference Call on May 6 https://t.co/Bswi1mwqgf
+ My List
MREO Mereo BioPharma Group plc - American Depositary Shares 8.5% 8.5% 0 + Biopharma, Cancer fight, Country: Greate Britain


Last highlighted: #MREO SEC report: Mereo Biopharma Group plc Registration statement by foreign private issuers
SEC Filing Form F-3 filed by Mereo Biopharma Group plc -- SEC File Number 211148904
+ My List
MTP Midatech Pharma PLC - American Depositary Shares 0 + Country: Greate Britain, Medicine, 3D, Pharmaceutical


Last highlighted: $MTP 📜 SEC Form 6-K filed by Midatech Pharma PLC https://t.co/bXrzkJUXsF #majorpharmaceuticals #healthcare
+ My List
RNLX Renalytix AI plc - American Depositary Shares 15.32% 15.32% 0 + Country: Greate Britain, Medicine, Disease: Kidney, Artificial Intelligence


Last highlighted: $RNLX 6-K Renalytix AI (2 Mar, 6:10am) 📰 RenalytixAI Reports Financial Results for Second Quarter of Fiscal Year 2021 https://t.co/XIBCrGVTeh #RNLX #6K #RenalytixAI #News
+ My List
VRNA Verona Pharma plc - American Depositary Shares 1.36% down 7.92% -6.56 + Respiratory therapies / Pulmanory, Country: Greate Britain, Medicine


Last highlighted: #VRNA SEC report: Verona Pharma plc Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Verona Pharma plc -- SEC File Number
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.